One study found that out of 18 patients with SLE and thrombocytopenia, 14 had anticardiolipin (aCL) antibodies and the relative risk for thrombocytopenia in patients with aCL antibodies was greater than four [32]. Here, ACLY is linked to Thrombocytopenia.